PGEN
PRECIGEN, INC.
Key Financials
Operating Income
$-110507000
↑ 18.2%
Net Income
$-250642000
↓ 98.6%
Revenue
$9.7M
↑ 146.7%
Total Liabilities
$134.6M
↑ 71.4%
Total Assets
$155.5M
↑ 7.0%
Shareholders' Equity
$20.9M
↓ 45.7%
EPS (Diluted)
$-1.37
↓ 191.5%
Cash & Equivalents
$30.2M
↑ 2.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 8/7/2026 | View on SEC |
| SCHEDULE 13G/A | 8/7/2026 | View on SEC |
| 144 | 8/6/2026 | View on SEC |
| 10-Q | 8/4/2026 | View on SEC |
| 8-K | 8/4/2026 | View on SEC |
| 4 | 8/3/2026 | View on SEC |
| 144 | 8/3/2026 | View on SEC |
| 4 | 7/31/2026 | View on SEC |
| 144 | 7/31/2026 | View on SEC |
| 4 | 7/1/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PGEN |
| Company Name | PRECIGEN, INC. |
| CIK | 1356090 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | VA |
| Phone | 301-556-9900 |